Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Bladder cancer cell-intrinsic PD-L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy

  • Deyi Zhang
  • , Ryan M. Reyes
  • , Erica Osta
  • , Suresh Kari
  • , Harshita B. Gupta
  • , Alvaro S. Padron
  • , Anand V.R. Kornepati
  • , Aravind Kancharla
  • , Xiujie Sun
  • , Yilun Deng
  • , Bogang Wu
  • , Ratna Vadlamudi
  • , Rong Li
  • , Robert S. Svatek
  • , Tyler J. Curiel

Producción científica: Article › revisión exhaustiva

Resumen

Tumor cell-intrinsic programmed death-ligand 1 (PD-L1) signals mediate immunopathologic effects in breast, colon, and ovarian cancers and in melanomas, but bladder cancer (BC) effects are unreported. We show here that BC cell-intrinsic PD-L1 signals in mouse MB49 and human RT4, UM-UC3, and UM-UC-14 BC cells regulate important pathologic pathways and processes, including effects not reported in other cancers. α-PD-L1 antibodies reduced BC cell proliferation in vitro, demonstrating direct signaling effects. BC cell-intrinsic PD-L1 promoted mammalian target of rapamycin complex 1 (mTORC1) signals in vitro and augmented in vivo immune-independent cell growth and metastatic cancer spread, similar to effects we reported in melanoma and ovarian cancer. BC cell-intrinsic PD-L1 signals also promoted basal and stress-induced autophagy, whereas these signals inhibited autophagy in melanoma and ovarian cancer cells. BC cell-intrinsic PD-L1 also mediated chemotherapy resistance to the commonly used BC chemotherapy agents cis-platinum and gemcitabine and to the mTORC1 inhibitor, rapamycin. Thus, BC cell-intrinsic PD-L1 signals regulate important virulence and treatment resistance pathways that suggest novel, actionable treatment targets meriting additional studies. As a proof-of-concept, we showed that the autophagy inhibitor chloroquine improved cis-platinum treatment efficacy in vivo, with greater efficacy in PD-L1 null versus PD-L1-replete BC.

Idioma originalEnglish (US)
Páginas (desde-hasta)2137-2152
Número de páginas16
PublicaciónCancer Medicine
Volumen10
N.º6
DOI
EstadoPublished - mar 2021

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Huella

Profundice en los temas de investigación de 'Bladder cancer cell-intrinsic PD-L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy'. En conjunto forman una huella única.

Citar esto